Dallas, TX -- (SBWIRE) -- 06/22/2015 -- The report "Retinoblastoma - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Retinoblastoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinoblastoma and special features on late-stage and discontinued projects.

Complete report on Retinoblastoma with 21 market data tables and 13 figures, spread across 57 pages is available at
http://www.rnrmarketresearch.com/retinoblastoma-pipeline-review-h1-2015-market-report.html

Companies discussed in this Retinoblastoma - Pipeline Review, H1 2015 report include BioLineRx, Ltd., Cellceutix Corporation, Icon Bioscience, Inc., Neotropix, Inc., Recombio S.L, RXi Pharmaceuticals Corporation.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are BL-8040, Kevetrin, melphalan, NTX-010, nutlin-3, racotumomab, RNAi Oligonucleotide for Retinoblastoma.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=392686
(This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases Cover by this report includes:

-Mar 08, 2013: Cellceutix Announces Positive Preclinical Trial Data Of Kevetrin In Retinoblastoma
-Jan 03, 2013: Icon's Melphalan Intraocular Injection Receives US Orphan Drug Designation For Treatment Of Retinoblastoma

List of Tables
Number of Products under Development for Retinoblastoma, H1 2015 7
Number of Products under Development for Retinoblastoma - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Products under Investigation by Universities/Institutes, H1 2015 14
Retinoblastoma - Pipeline by BioLineRx, Ltd., H1 2015 15
Retinoblastoma - Pipeline by Cellceutix Corporation, H1 2015 16
Retinoblastoma - Pipeline by Icon Bioscience, Inc., H1 2015 17
Retinoblastoma - Pipeline by Neotropix, Inc., H1 2015 18
Retinoblastoma - Pipeline by Recombio S.L, H1 2015 19
Retinoblastoma - Pipeline by RXi Pharmaceuticals Corporation, H1 2015 20
Assessment by Monotherapy Products, H1 2015 21
Number of Products by Stage and Target, H1 2015 23
Number of Products by Stage and Mechanism of Action, H1 2015 25
Number of Products by Stage and Route of Administration, H1 2015 27
Number of Products by Stage and Molecule Type, H1 2015 29
Retinoblastoma Therapeutics - Recent Pipeline Updates, H1 2015 42
Retinoblastoma - Dormant Projects, H1 2015 53

List of Figures
Number of Products under Development for Retinoblastoma, H1 2015 7
Number of Products under Development for Retinoblastoma - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 12
Assessment by Monotherapy Products, H1 2015 21
Number of Products by Top 10 Targets, H1 2015 22
Number of Products by Stage and Top 10 Targets, H1 2015 23
Number of Products by Top 10 Mechanism of Actions, H1 2015 24
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 25
Number of Products by Top 10 Routes of Administration, H1 2015 26
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 27
Number of Products by Top 10 Molecule Types, H1 2015 28
Number of Products by Stage and Top 10 Molecule Types, H1 2015 29

Explore more reports on cancer therapeutics at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/cancer-therapeutics

About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.